PRKCQ and metastatic malignant neoplasm in the lymph nodes: However, a noteworthy observation emerged regarding the incidence of lymph node metastasis, TNM stage, and neoplasm differentiation in LUAD patients, wherein those classified within the PRKCQ-AS1 low-expression group (Table 1) and the miR-582-3p high-expression group (Table 2) exhibited more pronounced severity than their counterparts in the other groups (P < 0.05).